-國際醫療科技產業供應鏈合作論壇-
台日藥物創新與商機合作論壇
日本藥企為在全球醫藥品開發競爭上彎道超車，積極透過創新科技的賦能，加速利基醫藥品的開發。本論壇與日本藥物授權協會共同舉辦，邀請日本近期備受矚目的以AI加速孤兒新藥的SOCIUM以及創舉奈米科技免疫癌症新療法的United Immunity，分享臨床研究進展，並進一步促成雙邊研發製造等優勢的整合性合作吸引更大市場商機。
舉辦日期：2021年12月01日13:00 (GMT+8)；14:00 (GMT+9)線上首播。
舉辦地點：線上: Healthcare+ B2B台灣醫療科技商機平台
Organiser:
Taiwan:
Research Center for Biotechnology and Medicine Policy (財團法人生技醫療科技政策研究中心)
Development Center for Biotechnology (財團法人生物技術開發中心)
Japan:
Japan Pharmaceutical Licensing Association
Agenda
Time (GMT+8)
Topic
Speaker
Video
13:00-13:05
Opening Remark
Chung-Hsiun Wu, President, Development Center for Biotechnology (DCB)
Time (GMT+8)
Topic
Speaker
Video
13:05-13:10
Opening Remark
Kazuko Yokota, Represevtive, Japan Pharmaceutical Licensing Association (JPLA)
Time (GMT+8)
Topic
Speaker
Video
13:10-13:30
Keynote Speech The Power of Science Innovation in Japan ~ what we do well and where we need help ~
Toru Jay Seo, CEO, Lucidaim
Company Session
Time (GMT+8)
Topic
Speaker
Video
13:30-13:40
A future trend of AI-driven drug discovery and development.
Hiroshi Kawai, CEO, SOCIUM
Time (GMT+8)
Topic
Speaker
Video
13:40-13:50
Transforming Cancer Immunotherapy by Utilizing a Novel Tumor-Associated Macrophage-Selective Nanoparticulate Delivery System
Harada Naozumi, CEO, United Immunity
Time (GMT+8)
Topic
Speaker
Video
13:50-14:00
Innovations for health. TTS for improved patients’outcome
Stefan Arnold, Director Business Development Asia, LTS Lohmann Therapie-Systeme AG
Time (GMT+8)
Topic
Speaker
Video
14:00-14:10
Common challenges for business development at SMEs, and lean BD scheme
Kazushi Kamitani, Managing Director, Japan Pharma Research Office
Time (GMT+8)
Topic
Speaker
Video
14:10-14:20
Novel Medications For Better Elderly Care - Patch and Oral Film.
Milky Kao, Vice President BD, TAHO Pharmaceuticals Ltd.
Time (GMT+8)
Topic
Speaker
Video
14:20-14:30
AD17002 in Mucosal Immunotherapy
Bryon Chen, Chairman, Advagene Biopharma Co., Ltd.
Time (GMT+8)
Topic
Speaker
Video
14:30-14:40
AI-assisted medicine, genomics information and clinical data analysis solutions.
Ethan Tu, Founer, Taiwan AI labs